Literature DB >> 28849787

Therapy: Immunotherapy advance for T1DM.

Claire Greenhill.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28849787     DOI: 10.1038/nrendo.2017.113

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Authors:  Mohammad Alhadj Ali; Yuk-Fun Liu; Sefina Arif; Danijela Tatovic; Hina Shariff; Vivienne B Gibson; Norkhairin Yusuf; Roman Baptista; Martin Eichmann; Nedyalko Petrov; Susanne Heck; Jennie H M Yang; Timothy I M Tree; Irma Pujol-Autonell; Lorraine Yeo; Lucas Baumard; Rachel Stenson; Alex Howell; Alison Clark; Zoe Boult; Jake Powrie; Laura Adams; Florence S Wong; Stephen Luzio; Gareth Dunseath; Kate Green; Alison O'Keefe; Graham Bayly; Natasha Thorogood; Robert Andrews; Nicola Leech; Frank Joseph; Sunil Nair; Susan Seal; HoYee Cheung; Craig Beam; Robert Hills; Mark Peakman; Colin M Dayan
Journal:  Sci Transl Med       Date:  2017-08-09       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.